Stock Research for LMNX


Featured Broker: Ally Invest

Get the due diligence for another stock.


LMNX Stock Chart & Research Data

The LMNX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LMNX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


LMNX Due diligence Resources & Stock Charts

The LMNX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LMNX Detailed Price Forecast - CNN Money CNN View LMNX Detailed Summary - Google Finance
Yahoo View LMNX Detailed Summary - Yahoo! Finance Zacks View LMNX Stock Research & Analysis -

Stock Analysis

TradeIdeas View LMNX Trends & Analysis - Trade-Ideas Barrons View LMNX Major Holders - Barrons
NASDAQ View LMNX Call Transcripts - NASDAQ Seeking View LMNX Breaking News & Analysis - Seeking Alpha
Spotlight View LMNX Annual Report - OTC Report View LMNX OTC Short Report -
TradeKing View LMNX Fundamentals - TradeKing Charts View LMNX SEC Filings - Bar Chart
WSJ View Historical Prices for LMNX - The WSJ Morningstar View Performance/Total Return for LMNX - Morningstar
MarketWatch View the Analyst Estimates for LMNX - MarketWatch CNBC View the Earnings History for LMNX - CNBC
StockMarketWatch View the LMNX Earnings - StockMarketWatch MacroAxis View LMNX Buy or Sell Recommendations - MacroAxis
Bullish View the LMNX Bullish Patterns - American Bulls Short Pains View LMNX Short Pain Metrics -

Social Media Mentions

StockTwits View LMNX Stock Mentions - StockTwits PennyStocks View LMNX Stock Mentions - PennyStockTweets
Twitter View LMNX Stock Mentions - Twitter Invest Hub View LMNX Investment Forum News - Investor Hub
Yahoo View LMNX Stock Mentions - Yahoo! Message Board Seeking Alpha View LMNX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for LMNX - Insider Cow View Insider Transactions for LMNX - Insider Cow
CNBC View LMNX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LMNX - OTC Markets
Yahoo View Insider Transactions for LMNX - Yahoo! Finance NASDAQ View Institutional Holdings for LMNX - NASDAQ

Stock Charts

FinViz View LMNX Stock Insight & Charts - StockCharts View LMNX Investment Charts -
BarChart View LMNX Stock Overview & Charts - BarChart Trading View View LMNX User Generated Charts - Trading View

Latest Financial News for LMNX

Luminex Corporation to Acquire MilliporeSigma's Flow Cytometry Portfolio
Posted on Sunday October 21, 2018

AUSTIN, Texas, Oct. 22, 2018 /PRNewswire/ -- On October 18, Luminex Corporation (NASDAQ: LMNX) announced that the company has signed a definitive agreement to acquire MilliporeSigma's flow cytometry portfolio for $75 million, consisting of approximately $69.9 million to be paid under a Stock and Asset Purchase Agreement and approximately $5.1 million in committed inventory purchases. The acquisition expands Luminex's existing offering of flow-based detection systems, which is centered around its innovative xMAP® multiplexing technology, with more than 15,000 xMAP systems sold worldwide. MilliporeSigma's flow cytometry portfolio includes Amnis®, the market-leading family of imaging flow cytometry products for cell-based analysis, as well as their Guava® portfolio of products, which are economical, high-performance systems based on microcapillary technologies.

Market Trends Toward New Normal in LSC Communications, Corindus Vascular Robotics, Sprouts Farmers Market, Luminex, ChromaDex, and CareDx — Emerging Consolidated Expectations, Analyst Ratings
Posted on Thursday October 18, 2018

NEW YORK, Oct. 18, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018
Posted on Monday October 15, 2018

AUSTIN, Texas , Oct. 15, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter ended September 30, 2018 on Monday, November 5, ...

Molecular Diagnostic Market Gains Momentum: 3 Stocks in Focus
Posted on Thursday October 11, 2018

Rising incidence of infectious diseases and increasing acceptance of companion diagnostics are driving the molecular diagnostics market.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.